NGM Biopharmaceuticals, Inc. EBIT Margin 2019-2023 | NGM
Current and historical EBIT (Earnings Before Interest & Taxes) margin for NGM Biopharmaceuticals, Inc. (NGM) over the last 10 years. The current EBIT profit margin for NGM Biopharmaceuticals, Inc. as of December 31, 2023 is .
| EBIT Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBIT | EBIT Margin |
| 2023-12-31 | $0.00B | $-0.15B | -3800.00% |
| 2023-09-30 | $0.02B | $-0.16B | -727.27% |
| 2023-06-30 | $0.03B | $-0.18B | -610.34% |
| 2023-03-31 | $0.04B | $-0.18B | -508.33% |
| 2022-12-31 | $0.06B | $-0.17B | -301.82% |
| 2022-09-30 | $0.06B | $-0.16B | -267.24% |
| 2022-06-30 | $0.07B | $-0.14B | -197.10% |
| 2022-03-31 | $0.08B | $-0.13B | -161.54% |
| 2021-12-31 | $0.08B | $-0.12B | -153.16% |
| 2021-09-30 | $0.08B | $-0.12B | -156.41% |
| 2021-06-30 | $0.08B | $-0.12B | -150.00% |
| 2021-03-31 | $0.09B | $-0.11B | -131.76% |
| 2020-12-31 | $0.09B | $-0.11B | -120.69% |
| 2020-09-30 | $0.10B | $-0.09B | -95.92% |
| 2020-06-30 | $0.10B | $-0.08B | -79.38% |
| 2020-03-31 | $0.10B | $-0.06B | -59.80% |
| 2019-12-31 | $0.10B | $-0.05B | -47.12% |
| 2019-09-30 | $0.12B | $-0.02B | -15.83% |
| 2019-06-30 | $0.12B | $-0.01B | -11.76% |
| 2019-03-31 | $0.12B | $-0.01B | -6.90% |
| 2018-12-31 | $0.11B | $-0.00B | -3.67% |
